Clearside Biomedical, Inc. Common Stock (CLSD) Return on Equity (ROE) (2016 - 2025)
Clearside Biomedical, Inc. Common Stock (CLSD) Return on Equity (ROE) from Jun 30, 2016 to Sep 30, 2025. The TTM Clearside Biomedical, Inc. Common Stock (CLSD) Return on Equity (ROE) is 11.07%. You can export chart.
Annual ROE
Quarterly ROE
Annual Return on Equity (ROE) change of Clearside Biomedical, Inc. Common Stock (CLSD)
| Year | Return on Equity (ROE) | Change |
|---|---|---|
| 2024 | 88.42% | -56.69% |
| 2023 | 204.15% | -165.74% |
| 2022 | -310.56% | -31139.26% |
| 2021 | 1.00% | -100.48% |
| 2020 | -207.88% | -24.61% |
| 2019 | -275.72% | -21.37% |
| 2018 | -350.64% | +27.36% |
| 2017 | -275.30% | +662.30% |
| 2016 | -36.11% | N/A |